???pagination.result.count???
???pagination.result.page???
1
Functional limb muscle innervation prior to cholinergic transmitter specification during early metamorphosis in Xenopus. , Lambert FM ., Elife. May 30, 2018; 7
Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors. , Masuko T., J Pharmacol Exp Ther. November 1, 2009; 331 (2): 522-30.
Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors. , Cavara NA., BMC Neurosci. April 6, 2009; 10 32.
Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. , Mony L., Mol Pharmacol. January 1, 2009; 75 (1): 60-74.
Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor. , Han X., J Neurochem. December 1, 2008; 107 (6): 1566-77.
Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/ NR2A and NR1/ NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. , Frizelle PA., Mol Pharmacol. September 1, 2006; 70 (3): 1022-32.
Nickel differentially affects NMDA receptor channels in developing cultured rat neurons. , Gavazzo P., Dev Biol. March 17, 2006; 1078 (1): 71-9.
Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis. , Hansen KB., Mol Pharmacol. December 1, 2005; 68 (6): 1510-23.
NMDA receptors as targets of heavy metal interaction and toxicity. , Marchetti C., Neurotox Res. November 1, 2005; 8 (3-4): 245-58.
Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids. , Conti P., J Med Chem. October 6, 2005; 48 (20): 6315-25.
Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. , Kinarsky L., J Pharmacol Exp Ther. June 1, 2005; 313 (3): 1066-74.
Corymine potentiates NMDA-induced currents in Xenopus oocytes expressing NR1a/ NR2B glutamate receptors. , Leewanich P., J Pharmacol Sci. May 1, 2005; 98 (1): 58-65.
Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. , Morley RM., J Med Chem. April 7, 2005; 48 (7): 2627-37.
The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. , Feng B., Neuropharmacology. March 1, 2005; 48 (3): 354-9.
The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. , Rachline J., J Neurosci. January 12, 2005; 25 (2): 308-17.
Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner. , Masuko T., Neurosci Lett. November 16, 2004; 371 (1): 30-3.
Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus. , Lozovaya NA., J Physiol. July 15, 2004; 558 (Pt 2): 451-63.
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity. , Jang MK., Proc Natl Acad Sci U S A. May 25, 2004; 101 (21): 8198-8203.
Differential modulation of NR1- NR2A and NR1- NR2B subtypes of NMDA receptor by PDZ domain-containing proteins. , Iwamoto T., J Neurochem. April 1, 2004; 89 (1): 100-8.
Structure-activity analysis of a novel NR2C/ NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. , Feng B., Br J Pharmacol. February 1, 2004; 141 (3): 508-16.
Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket. , Malherbe P., J Pharmacol Exp Ther. December 1, 2003; 307 (3): 897-905.
Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner. , Levine JB., Neurosci Lett. August 7, 2003; 346 (3): 125-8.
Structural model of the N-methyl-D-aspartate receptor glycine site probed by site-directed chemical coupling. , Foucaud B., J Biol Chem. June 27, 2003; 278 (26): 24011-7.
ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity. , Ortinau S., J Neurosci. June 15, 2003; 23 (12): 4996-5003.
Oxygen sensitivity of NMDA receptors: relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons. , Bickler PE., Neuroscience. January 1, 2003; 118 (1): 25-35.